The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends flat ahead of Fed decision; GSK slumps on weak earnings

Wed, 29th Jul 2020 09:04

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* GSK hits 15-week low on profit miss

* Barclays falls as loan loss provisions grow

* Next jumps on posting smaller-than-feared slump in sales

* Consumer, tech stocks weigh on mid-cap index

* FTSE 100 up 0.04%, FTSE 250 down 0.2%
(Updates to close)

By Sagarika Jaisinghani and Susan Mathew

July 29 (Reuters) - The FTSE 100 ended flat on Wednesday as
investors held out for more stimulus from the U.S. Congress and
the Federal Reserve, while GlaxoSmithKline, Barclays and Taylor
Wimpey slid on weak quarterly earnings.

The world's largest vaccine maker, GSK, slumped 3.2%
to hit a 15-week low after missing second-quarter profit
estimates under the effect of coronavirus lockdowns, dragging
the healthcare index down 1.8%.

Kicking off the quarterly earnings season for UK banks,
Barclays set aside a higher-than-expected 1.6 billion
pounds ($2.07 billion) to cover a possible rise in loan losses
due to the COVID-19 pandemic. Its shares fell 6.1%.

But a 7.7% jump for Next Plc helped the blue-chip
FTSE 100 end in positive territory as the retailer
reported a smaller-than-feared slump in second-quarter sales.

The mid-cap FTSE 250 was off 0.2%, weighed by losses
in consumer discretionary, financial and tech-related stocks.

The Fed is expected to sound reassuringly accommodative at
its policy review due at 2 p.m. ET (1800 GMT), followed by Chair
Jerome Powell's press conference, but investors have turned wary
over political wrangling between U.S. Democrats and Republicans
on a coronavirus relief plan.

"Not much will come of (the Fed meeting) in terms of policy.
That said, we think a sober assessment from the Fed or Powell
could challenge risk sentiment," said Mazen Issa, senior FX
strategist at TD Securities.

"With COVID cases ravaging the U.S. and the job market
stalling, there is a risk that Powell sounds more bearish than
dovish."

Uncertainty about global efforts to contain the pandemic
stalled a three-month rally for the FTSE 100 in July. Although
recent economic data has shown a revival in business activity
with the lifting of nationwide lockdowns, traders are concerned
about the damage from another possible shutdown.

Homebuilder Taylor Wimpey Plc shed 8.1% on saying it
expected to complete around 40% fewer homes in 2020.

(Reporting by Sagarika Jaisinghani in Bengaluru; editing by
Uttaresh.V and Kevin Liffey)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.